Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/139015
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Germ cell arrest associated with aSETX mutation in ataxia oculomotor apraxia type 2
Author: Catford, S.R.
O'Bryan, M.K.
McLachlan, R.I.
Delatycki, M.B.
Rombauts, L.
Citation: Reproductive Biomedicine Online, 2019; 38(6):961-965
Publisher: Elsevier
Issue Date: 2019
ISSN: 1472-6483
1472-6491
Statement of
Responsibility: 
SR Catford, MK O'Bryan, RI McLachlan, MB Delatycki, L Rombauts
Abstract: Ataxia with oculomotor apraxia type 2 (AOA2) is a rare autosomal recessive neurodegenerative disorder characterized by cerebellar atrophy, peripheral neuropathy and oculomotor apraxia. It is caused by mutations in the SETX gene that encodes senataxin, a ubiquitously expressed protein that mediates processes, including transcription, transcription termination, DNA repair, RNA processing, DNA-RNA hybrid (R-loop) elimination and telomere stability. In mice, senataxin is essential for male germ cell development and fertility through its role in meiotic recombination and sex chromosome inactivation. AOA2 is associated with hypogonadism in women, but there are no reports of hypogonadism or infertility in men. We describe the first case of human male infertility caused by germ cell arrest in a man with AOA2. Our patient has a homozygous mutation in the SETX gene (NC_000009.11:g.135158775dup), which results in a frameshift and premature protein termination (NM_015046.6:c.6422dup, p.[Ser2142Glufs*23]). In accordance with the murine phenotype, testis histology revealed disrupted seminiferous tubules with spermatogonia and primary spermatocytes, but absent spermatids. Collectively, these data support an essential role of senataxin in human spermatogenesis, and provide a compelling case that men with AOA2 should be counselled at diagnosis about the possibility of infertility.
Keywords: Ataxia oculomotor apraxia type 2
Germ cell arrest
Male infertility
Non-obstructive azoospermia
Senataxin
SETX
Rights: © 2019 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
DOI: 10.1016/j.rbmo.2018.12.042
Grant ID: http://purl.org/au-research/grants/nhmrc/1022327
http://purl.org/au-research/grants/nhmrc/1058356
Published version: http://dx.doi.org/10.1016/j.rbmo.2018.12.042
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.